NMES to Improve Eyelid Functions in Cranial Nerve (CN) III and VII Palsy
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 19 - Any |
| Updated: | 2/17/2019 |
| Start Date: | January 6, 2017 |
| End Date: | December 2019 |
| Contact: | Raine Osborne, DPT |
| Email: | Raine.Osborne@Brooksrehab.org |
| Phone: | 904-345-6934 |
A Novel Treatment Using Neuromuscular Electrical Stimulation to Improve Eyelid Function in Patients With CN III and CN VII Palsy.
Traumatic brain injury, stroke and other neurological conditions may result in weakness of
the muscles that either open or close the eye. This is generally a result of impaired
functioning of the oculomotor or facial cranial nerves. Current treatments to improve eye
opening or closing are either invasive or largely ineffective. This study tests a noninvasive
means of improving eyelid opening and closing by applying a previously demonstrated safe and
effective neuromuscular electrical stimulation (NMES) intervention to the muscles controlling
eyelid movement. Participants in this study will either receive the investigational NMES
protocol 30 min per day for five days or a sham NMES for the same period. The primary outcome
for this study is the participants' ability to open or close their affected eye. Secondary
outcomes include additional measures of eye and corneal health.
the muscles that either open or close the eye. This is generally a result of impaired
functioning of the oculomotor or facial cranial nerves. Current treatments to improve eye
opening or closing are either invasive or largely ineffective. This study tests a noninvasive
means of improving eyelid opening and closing by applying a previously demonstrated safe and
effective neuromuscular electrical stimulation (NMES) intervention to the muscles controlling
eyelid movement. Participants in this study will either receive the investigational NMES
protocol 30 min per day for five days or a sham NMES for the same period. The primary outcome
for this study is the participants' ability to open or close their affected eye. Secondary
outcomes include additional measures of eye and corneal health.
Inclusion Criteria:
- Cranial nerve III (oculomotor nerve) and/or cranial nerve IV (facial nerve) palsy.
- Able to read and communicate in English.
Exclusion Criteria:
- Idiopathic onset of CN III and/or CN IV palsy.
- Traumatic injury to the eye or eyelid.
- Active wounds in the treatment area.
- Presence of swelling or infection in or surrounding the affected eye.
- Diminished sensation in the area to be treated.
We found this trial at
1
site
Jacksonville, Florida 32216
Principal Investigator: Kenneth Ngo, MD
Phone: 904-345-6934
Click here to add this to my saved trials
